Abstract
<div style="left: 70.8662px; top: 324.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.971046);" data-canvas-width="419.81549999999993">According to epidemiological studies, rates of social anxiety disorder</div><div style="left: 70.8662px; top: 344.72px; font-size: 15.45px; font-family: serif; transform: scaleX(1.11655);" data-canvas-width="424.26750000000004">(SAD) or social phobia range from 3% to 16% in the general</div><div style="left: 70.8662px; top: 364.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.987995);" data-canvas-width="69.1185">population.</div><div style="left: 139.985px; top: 365.947px; font-size: 9.00733px; font-family: serif; transform: scaleX(0.952064);" data-canvas-width="16.423109999999998">[1,2]</div><div style="left: 156.408px; top: 364.72px; font-size: 15.45px; font-family: serif; transform: scaleX(0.977187);" data-canvas-width="334.422">Social phobia and specific phobias have an earlier age</div>of onset than other anxiety disorders.
Highlights
According to epidemiological studies, rates of social anxiety disorder (SAD) or social phobia range from 3% to 16% in the general population.[1,2] Social phobia and specific phobias have an earlier age of onset than other anxiety disorders
SAD may be complicated by comorbid major depression, which is usually responsive to first-line therapy options (e.g. selective serotonin reuptake inhibitors (SSRIs) and dual-acting serotoninnorepinephrine reuptake inhibitors (SNRIs))
Current evidence clearly supports the use of SSRIs (escitalopram, fluvoxamine, fluvoxamine controlled release (CR), paroxetine, sertraline) and the Serotonin-norepinephrine reuptake inhibitors (SNRI) venlafaxine extended release (ER) as firstline pharmacological agents in the treatment of generalised social anxiety disorder (GSAD)
Summary
Rates of social anxiety disorder (SAD) or social phobia range from 3% to 16% in the general population.[1,2] Social phobia and specific phobias have an earlier age of onset than other anxiety disorders. The disorder typically persists throughout adult life and is associated with significant functional impairment.[3,4,5] Individuals with SAD are more likely to be females; in clinical samples SAD seems to be more distributed among men and women.[4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
